Regional Health Properties (RHE)

$2.77 +0.09 (3.51%)
Market Cap 5.21M
Revenue (ttm) 17.16M
Net Income (ttm) -3.89M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -22.67%
Debt to Equity Ratio -19.45
Volume 40,200
Avg Vol 915,716
Day's Range N/A - N/A
Shares Out 1.88M
Stochastic %K 76%
Beta 1.01
Analysts Strong Buy
Price Target N/A
bottomBeast
bottomBeast Apr. 18 at 10:03 AM
$RHE I'm already up 25%
0 · Reply
meszaros
meszaros Apr. 8 at 2:38 PM
$RHE The white dashed lines on the chart indicate the price targets. Based on the report, RHEP has strong fundamental potential — the current 5x P/E ratio is significantly below the healthcare sector average. The $3–5 range appears to be a realistic mid-term target if the market recognizes the results.
0 · Reply
meszaros
meszaros Apr. 8 at 10:04 AM
$RHE The core operations are moving in the right direction. Patient care revenue increased to $36.1 million from $11.3 million, and $11.7 million in pharmacy revenue also appeared, indicating that the SunLink deal has genuinely reshaped the revenue mix.
0 · Reply
meszaros
meszaros Apr. 8 at 10:02 AM
$RHE The headline numbers are strong: in 2025, revenue increased to $53.2 million from $18.3 million in 2024, while net income came in at $3.37 million compared to a $3.22 million loss previously. In Q4, a similar jump is visible, with $20.8 million in revenue and $2.7 million in net income.
0 · Reply
meszaros
meszaros Apr. 8 at 9:57 AM
$RHE ~$4–5M market cap, OTC inefficiency, and improving fundamentals. That’s the kind of combination where even a small shift in sentiment or liquidity can reprice the stock aggressively. If they can convert earnings into consistent operating cash flow and keep deleveraging, this can move from “distressed microcap” to “early recovery play” very fast. This is still risky, but from a bull perspective, it’s exactly the kind of underfollowed turnaround where the upside comes from multiple expansion + execution, not hype.
0 · Reply
meszaros
meszaros Apr. 8 at 9:56 AM
$RHE RHEP is starting to look like a classic microcap turnaround that the market hasn’t priced yet. The latest numbers show real improvement, not just accounting noise. Revenue is scaling, margins are stabilizing, and most importantly, they printed positive net income and EPS, which is rare at this size. The SunLink merger is clearly doing its job. Occupancy jumped meaningfully, patient volumes are rising, and the payer mix is improving — that’s exactly what you want to see in a healthcare RE/ops hybrid. This isn’t just top-line growth, it’s quality of revenue improving, which typically leads to better cash flow over time. On capital structure, buying back preferred shares at a discount is a strong signal. Management is effectively deleveraging in a smart way, reducing future dilution pressure and cleaning up the balance sheet without burning full cash value.
0 · Reply
meszaros
meszaros Apr. 8 at 9:54 AM
$RHE On the operational side, the picture is improving. According to management, the SunLink merger has significantly expanded the platform. Portfolio occupancy increased from 62.5% to 72.2% year-over-year, while in the HealthCare Services segment, Average Daily Census rose from 389 to 467, and the quality mix improved from 9.1% to 12.2%. In addition, the company sold a non-core asset, the Coosa Valley facility, realizing a $2.7 million gain. From a capital structure perspective, there has also been movement. The company repurchased 511,099 shares of Series B preferred stock at a discount, which is a positive signal for shareholders as it shows management is attempting to reduce the preferred equity burden at an attractive price. However, the balance sheet is still not clean: total debt stood at $44.0 million at year-end, and the company reported $2.3 million in operating cash outflow for 2025. So despite generating a profit, the cash flow profile is not yet fully convincing.
0 · Reply
meszaros
meszaros Apr. 8 at 9:52 AM
$RHE https://www.globenewswire.com/news-release/2026/04/07/3269368/0/en/Regional-Health-Properties-Reports-Fourth-Quarter-2025-Results.html Based on the latest market information, Regional Health Properties Inc. is now trading on the OTCQB under the ticker RHEP, and the recently released Q4 2025 and full-year 2025 results are the main near-term catalyst for the stock. For full-year 2025, the company reported $53.2 million in revenue, $3.4 million in GAAP net income, and $1.09 in EPS. In the fourth quarter alone, revenue came in at $20.8 million, with $2.7 million in net income and $0.68 in EPS.
0 · Reply
bottomBeast
bottomBeast Apr. 3 at 8:46 PM
$RHE this is at a great price to buy. I wanted to today then found out market is closed.
0 · Reply
F0moSapien
F0moSapien Mar. 14 at 10:10 AM
$RHE Any update about this ?
0 · Reply
Latest News on RHE
No data available.
bottomBeast
bottomBeast Apr. 18 at 10:03 AM
$RHE I'm already up 25%
0 · Reply
meszaros
meszaros Apr. 8 at 2:38 PM
$RHE The white dashed lines on the chart indicate the price targets. Based on the report, RHEP has strong fundamental potential — the current 5x P/E ratio is significantly below the healthcare sector average. The $3–5 range appears to be a realistic mid-term target if the market recognizes the results.
0 · Reply
meszaros
meszaros Apr. 8 at 10:04 AM
$RHE The core operations are moving in the right direction. Patient care revenue increased to $36.1 million from $11.3 million, and $11.7 million in pharmacy revenue also appeared, indicating that the SunLink deal has genuinely reshaped the revenue mix.
0 · Reply
meszaros
meszaros Apr. 8 at 10:02 AM
$RHE The headline numbers are strong: in 2025, revenue increased to $53.2 million from $18.3 million in 2024, while net income came in at $3.37 million compared to a $3.22 million loss previously. In Q4, a similar jump is visible, with $20.8 million in revenue and $2.7 million in net income.
0 · Reply
meszaros
meszaros Apr. 8 at 9:57 AM
$RHE ~$4–5M market cap, OTC inefficiency, and improving fundamentals. That’s the kind of combination where even a small shift in sentiment or liquidity can reprice the stock aggressively. If they can convert earnings into consistent operating cash flow and keep deleveraging, this can move from “distressed microcap” to “early recovery play” very fast. This is still risky, but from a bull perspective, it’s exactly the kind of underfollowed turnaround where the upside comes from multiple expansion + execution, not hype.
0 · Reply
meszaros
meszaros Apr. 8 at 9:56 AM
$RHE RHEP is starting to look like a classic microcap turnaround that the market hasn’t priced yet. The latest numbers show real improvement, not just accounting noise. Revenue is scaling, margins are stabilizing, and most importantly, they printed positive net income and EPS, which is rare at this size. The SunLink merger is clearly doing its job. Occupancy jumped meaningfully, patient volumes are rising, and the payer mix is improving — that’s exactly what you want to see in a healthcare RE/ops hybrid. This isn’t just top-line growth, it’s quality of revenue improving, which typically leads to better cash flow over time. On capital structure, buying back preferred shares at a discount is a strong signal. Management is effectively deleveraging in a smart way, reducing future dilution pressure and cleaning up the balance sheet without burning full cash value.
0 · Reply
meszaros
meszaros Apr. 8 at 9:54 AM
$RHE On the operational side, the picture is improving. According to management, the SunLink merger has significantly expanded the platform. Portfolio occupancy increased from 62.5% to 72.2% year-over-year, while in the HealthCare Services segment, Average Daily Census rose from 389 to 467, and the quality mix improved from 9.1% to 12.2%. In addition, the company sold a non-core asset, the Coosa Valley facility, realizing a $2.7 million gain. From a capital structure perspective, there has also been movement. The company repurchased 511,099 shares of Series B preferred stock at a discount, which is a positive signal for shareholders as it shows management is attempting to reduce the preferred equity burden at an attractive price. However, the balance sheet is still not clean: total debt stood at $44.0 million at year-end, and the company reported $2.3 million in operating cash outflow for 2025. So despite generating a profit, the cash flow profile is not yet fully convincing.
0 · Reply
meszaros
meszaros Apr. 8 at 9:52 AM
$RHE https://www.globenewswire.com/news-release/2026/04/07/3269368/0/en/Regional-Health-Properties-Reports-Fourth-Quarter-2025-Results.html Based on the latest market information, Regional Health Properties Inc. is now trading on the OTCQB under the ticker RHEP, and the recently released Q4 2025 and full-year 2025 results are the main near-term catalyst for the stock. For full-year 2025, the company reported $53.2 million in revenue, $3.4 million in GAAP net income, and $1.09 in EPS. In the fourth quarter alone, revenue came in at $20.8 million, with $2.7 million in net income and $0.68 in EPS.
0 · Reply
bottomBeast
bottomBeast Apr. 3 at 8:46 PM
$RHE this is at a great price to buy. I wanted to today then found out market is closed.
0 · Reply
F0moSapien
F0moSapien Mar. 14 at 10:10 AM
$RHE Any update about this ?
0 · Reply
Jdolar
Jdolar Feb. 4 at 10:07 AM
$RHE is this going to be listed again?
1 · Reply
meszaros
meszaros Jan. 5 at 8:38 PM
$RHE Regional Health Properties, Inc. (RHEP) — The Coosa Valley asset sale closed on Nov 10, 2025, so the cash impact and gain will be recognized in Q4 2025 results, which RHEP historically releases between late February and mid-April (most recently early/mid-April). On impact: the $10.6M sale value is material versus prior quarters. Compared with historical quarterly revenue (~$5–6M), this represents roughly a +70% to +190% uplift on a quarterly basis (one-time), with a meaningful cash flow boost that can fund preferred buybacks, reduce risk, and strengthen liquidity. Bottom line: timing is Q4’25, visibility comes with the Q4 report, and the magnitude is large enough to matter for common shareholders.
0 · Reply
meszaros
meszaros Jan. 5 at 7:46 PM
$RHE Regional Health Properties, Inc. (RHEP)’s ongoing Series B preferred buybacks send a clear message: management is focused on the survival and long-term value creation of the common equity. Retiring 12.5% cumulative preferred shares directly reduces senior claims ahead of common shareholders, lowers fixed cash burdens, and improves the residual value of the common. This is not short-term optics — it’s a structural decision that prioritizes common shareholders over expensive legacy capital. In plain terms: fewer preferred claims mean less dilution of value, lower risk, and more upside for the common if operations stabilize. Actions matter, and these buybacks show management’s interests are aligned with common equity holders.
0 · Reply
meszaros
meszaros Jan. 5 at 7:05 PM
$RHE https://www.tradingview.com/chart/RHEP/088pADGF-Fundamental-Rerating-Ahead/
0 · Reply
meszaros
meszaros Jan. 5 at 6:58 PM
$RHE In short: this is not cosmetic financial engineering. It’s a transfer of value from high-cost preferred capital to common shareholders, and a constructive signal for long-term minority holders.
0 · Reply
meszaros
meszaros Jan. 5 at 6:57 PM
$RHE Regional Health Properties, Inc. (RHEP) announced the repurchase of an additional 161,470 shares of its 12.5% Series B cumulative preferred stock, reducing the outstanding preferred count to ~1.72M shares. This is directly beneficial for common shareholders. The Series B carries a very expensive 12.5% cumulative dividend, so every preferred share retired permanently reduces fixed claims ahead of the common, lowers future cash outflows, and improves the residual value for minority holders. Importantly, these buybacks are typically executed at a discount to par, which is effectively deleveraging at below face value—a classic value-accretive move. Less preferred overhang = cleaner capital structure, lower risk, and better upside participation for common equity if operations stabilize.
0 · Reply
meszaros
meszaros Jan. 5 at 10:35 AM
$RHE The December-postponed annual shareholders’ meeting is being held today in Atlanta after the company failed to reach a quorum at the original December 30 date. The agenda and proposals remain unchanged, and previously submitted proxies are still valid unless revoked. Today’s meeting is mainly procedural, yet it matters because approval of governance items is necessary to keep the company compliant and operational, especially given RHEP’s ongoing liquidity and balance-sheet stress.
0 · Reply
Stoltz13
Stoltz13 Dec. 31 at 8:41 PM
$RHE the RHEPB shares jumped up to $6.25
0 · Reply
meszaros
meszaros Dec. 31 at 1:39 PM
$RHE Regional Health Properties Inc. 2025 Annual Meeting agenda (adjourned due to no quorum) mainly covered board elections, approval of the Amended & Restated 2023 Omnibus Incentive Compensation Plan, advisory Say-on-Pay votes (including frequency), and ratification of the auditor (Cherry Bekaert, LLP). No operational turnaround items — mostly governance and compensation matters. Meeting reconvenes Jan 5, 2026 with the same agenda.
0 · Reply
meszaros
meszaros Dec. 31 at 1:36 PM
$RHE Regional Health Properties Inc. adjourned its 2025 annual shareholder meeting due to lack of quorum. The meeting is rescheduled for January 5, 2026, with the same agenda and proposals. Previously submitted proxies remain valid. This highlights ongoing low shareholder participation and continued uncertainty around corporate actions.
0 · Reply
isaacwilliams33
isaacwilliams33 Nov. 26 at 12:50 AM
$RHE some straight vertical moment 😋
0 · Reply
Swing_Flip_Bluechip
Swing_Flip_Bluechip Nov. 25 at 4:20 PM
$RJET check out $RHE Your welcome may be a slow turn around but value there the just got a tender for $4 and rejected it for merger and cash infusion Easy play
0 · Reply